NADPH Oxidase 1 and Its Derived Reactive Oxygen Species Mediated Tissue Injury and Repair by Fu, Xiu-Jun et al.
 NADPH Oxidase 1 and Its Derived Reactive Oxygen Species
Mediated Tissue Injury and Repair
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Fu, Xiu-Jun, Ying-Bo Peng, Yi-Ping Hu, You-Zhen Shi, Min
Yao, and Xiong Zhang. 2014. “NADPH Oxidase 1 and Its
Derived Reactive Oxygen Species Mediated Tissue Injury and
Repair.” Oxidative Medicine and Cellular Longevity 2014 (1):
282854. doi:10.1155/2014/282854.
http://dx.doi.org/10.1155/2014/282854.
Published Version doi:10.1155/2014/282854
Accessed February 19, 2015 3:48:11 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12064559
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA
Review Article
NADPH Oxidase 1 and Its Derived Reactive Oxygen Species
Mediated Tissue Injury and Repair
Xiu-Jun Fu,1 Ying-Bo Peng,1 Yi-Ping Hu,1,2 You-Zhen Shi,1 Min Yao,1,3 and Xiong Zhang4
1 Department of Burns and Plastic Surgery, No. 3 People’s Hospital, Institute of Traumatic Medicine, School of Medicine,
Shanghai Jiao Tong University, Shanghai 201900, China
2Department of Burns, The Fourth Hospital Affiliated to Jinan University, Guangzhou 51022, China
3Department of Dermatology, Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital,
Boston, MA 02114, USA
4Department of Burns and Plastic Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University,
Shanghai 200025, China
Correspondence should be addressed to Xiong Zhang; xiong@medmail.com.cn
Received 5 September 2013; Revised 11 December 2013; Accepted 17 December 2013; Published 19 January 2014
Academic Editor: Mengzhou Xue
Copyright © 2014 Xiu-Jun Fu et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reactive oxygen species are mostly viewed to cause oxidative damage to various cells and induce organ dysfunction after
ischemia-reperfusion injury. However, they are also considered as crucial molecules for cellular signal transduction in biology.
NADPH oxidase, whose only function is reactive oxygen species production, has been extensively investigated in many cell types
especially phagocytes. The deficiency of NADPH oxidase extends the process of inflammation and delays tissue repair, which
causes chronic granulomatous disease in patients. NADPH oxidase 1, one member of the NADPH oxidase family, is not only
constitutively expressed in a variety of tissues, but also induced to increase expression in both mRNA and protein levels under
many circumstances. NADPH oxidase 1 and its derived reactive oxygen species are suggested to be able to regulate inflammation
reaction, cell proliferation and migration, and extracellular matrix synthesis, which contribute to the processes of tissue injury and
repair.
1. Introduction
The general view of the primary role of reactive oxygen
species (ROS) in biology is to cause oxidative damage to
organs and tissues suffering ischemia-reperfusion injury [1–
3] and inactivate and clear microorganisms through res-
piratory burst of phagocytic cells [4]. High concentration
of hydrogen peroxide is used clinically for wound disin-
fection, which might not be beneficial for overall wound
healing because of the oxidative damage to host tissue in
addition to bacteria [5, 6]. However, low concentration of
ROS regulates intracellular signal transduction pathways by
redox-dependent mechanisms, which facilitates the process
of tissue repair [6]. As signal transduction molecules, ROS
are controlling a large array of biological processes including
the regulation of organ development and cell growth and the
response to environmental stimuli [4]. In the process of tissue
injury and repair, ROS has both detrimental and beneficial
roles through regulating cell damages and promoting cell
proliferation and migration.
One of themost important sources of intracellular ROS is
the enzyme NADPH oxidase (Nox), which is the only mam-
malian enzyme dedicated to ROS generation. NADPH oxi-
dase enzyme complex, formed by Nox and other cytosolic
subunits, catalyzes the production of ROS from molecular
oxygen. The Nox family has been extensively investigated
in many cell types especially phagocytes [7]. The ROS and
their oxidants are critical for bacteria and necrotic tissue
purging by phagocytes. And the deficiency of Nox extends
the process of inflammation and delays tissue repair, which
causes chronic granulomatous disease (CGD) in patients [8].
NADPH oxidase was further found in extensive cell types
such as epithelial cells, fibroblasts, and vascular endothelial
cells [9]. A large number of evidence suggest that NADPH
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oxidase contributes to the initiation and development of
many physiological and pathophysiological events, including
thyroid hormone production in the thyroid gland, ischemia-
reperfusion injury in multiple organs, septic shock, obesity,
cancer, neuronal degeneration, and cardiovascular diseases,
as well as vascular diseases [10–12]. Based on these, Nox
and its derived ROS are suggested to play an essential
role in wound repair and regeneration, through modulating
inflammation reaction, cell proliferation and migration, and
extracellular matrix synthesis and deposition [13, 14].
Nox1 as the first discovered homologue of the catalytic
subunit of the superoxide-generating NADPH oxidase of
phagocytes is expressed in multiple organs and various cell
types, especially in colon epithelial cells and vascular smooth
muscle cells [15]. In addition to its constitutive expression in
a variety of tissues, Nox1 is induced to increase expression
in both mRNA and protein levels under many circumstances
such as proinflammatory factors and growth factors stimu-
lation, ultraviolet (UV) radiation, hypoxia, and mechanical
injury [16–19]. This review will focus on the possible roles
Nox1 plays in the process of tissue injury and repair mainly
through regulating the function of repair cells, namely epithe-
lial cells, fibroblast cells, and endothelial cells and smooth
muscle cells.
2. Nox Family and Nox1
In mammalian, the Nox enzymes can be divided into three
subfamilies: one containing Nox1–Nox4 (the Nox1–Nox4
subgroup), which form a heterodimer with p22phox; the Nox5
subfamily; and the Duox subfamily (Figure 1). All Nox
family members are transmembrane proteins that transport
electrons across biological membranes to reduce oxygen
to superoxide. In accordance with this preserved function,
there are conserved structural properties of Nox enzymes
that are common to all family members. Starting from the
COOH terminus, these conserved structural features include
an NADPH-binding site at the cytoplasmic COOH terminus,
a FAD-binding region in proximity of the NADPH-binding
site, six conserved transmembrane domains, and four highly
conserved heme-binding histidines in the third and fifth
transmembrane domains [7, 20]. A long intracellular NH
2
terminus containing a Ca2+-binding EF hand domain is
present in Nox5 and Duox proteins, distinguishing them
from Nox1–4. And given the additional NH
2
-terminal trans-
membrane domain, the histidines are in the fourth and sixth
transmembrane domains in Duox proteins [7].
Nox1 was the first homolog of Nox2 to be described. The
number and the length of the exons of the Nox1 genes are
virtually identical to Nox2. And at the protein level, similarly,
there is a high degree of sequence identity (57%) between
Nox1 and Nox2 [15]. Like Nox2, Nox1 is broadly expressed
in a variety of cell types, including vascular smooth muscle
cells, endothelial cells, uterus, placenta, prostate, osteoclasts,
and retinal pericytes, as well as in several cell lines such
as the colon tumor cell lines Caco2 and HT29 and the
pulmonary epithelial cell line A549 [7, 9, 15]. However, it
is most highly expressed in colon epithelium. Two cytosolic
subunits are necessary for Nox1 to generate superoxide. One
is Nox Organizer 1 (NoxO1) having the same role as p47phox,
while the other is Nox Activator 1 (NoxA1), which is similar
to p67phox. In addition to these two cytosolic subunits, Nox1
as well as Nox2 depends on the membrane subunit p22phox
[21, 22]. However, the dependence of Nox1 on subunit p22phox
is not so strict as its analoguesNox2 andNox3. LikeNox2, the
activation of Nox1 also depends on the Rac1, which provides
a major trigger for Nox1-dependent ROS generation [23].
ROS from Nox1 and other Nox isoforms can achieve the
regulation of cell proliferation, differentiation, survival, apop-
tosis, metabolism, and migration through redox-sensitive
cysteine residues. A very common targeted molecule by ROS
inside cell is protein tyrosine phosphorylations (PTPs), which
controls the phosphorylation of tremendous proteins involv-
ing cellular signal transduction [24]. Although the precise
mechanism is presently unknown, the mitogen-activated
protein kinase (MAPK) system and phosphoinositide 3-
kinase (PI3K) activated by the Nox family including Nox1
are shown in numerous studies (Figure 2) [24, 25]. Nox
isoforms derived ROS has also been suggested to regulate
some ion channels such as potassium channel andmembrane
and intracellular calcium channels. And these might happen
through the ROS-sensitive signaling systems. Interestingly,
Nox enzymes may reversibly be activated by the changing of
intracellular calcium [26]. In addition, abundant evidences
indicate that Nox-dependent ROS influence the expression of
multiple genes, including chemotactic factors, inflammatory
factors, and growth factors [27, 28].
3. The Activation of Nox1 in Epithelial
Cells and Wound Repair
The process of reepithelialization is critical for completing
wound healing. The epithelial cells from wound edges and
dermal appendages proliferate and migrate across the wound
and finally form a barrier between the wound and envi-
ronment. Emerging evidence indicates that ROS from Nox
and other resources regulate epithelial cells proliferation.
In physiological condition, Nox1 is mainly present in large
intestine epithelial cells, with much lower expression in
the small intestine (jejunum, ileum) and the uterine and
prostate [29]. However, constitutively expression of Nox1 and
cytosolic proteins Rac1, p40phox, and p67phox was identified as
a source of superoxide in human immortalized skin (HaCaT)
and gingival mucosal (GM16) keratinocyte cell lines [22].
Although Nox2 and Nox4 mRNA levels were also detected
in both cell lines, Nox1 but not Nox4 protein was detected in
HaCaT and GM16 cells, indicating that Nox1 may play a vital
role in redox-mediated signaling which is associated with
woundhealing after tissue injury and epithelial tumorigenesis
in human keratinocytes [22].
Rapidly increased NADPH oxidase activity and intra-
cellular ROS were also found on human keratinocytes after
treatment with a nontoxic dose of UVA radiation, which is a
major environmental stress on skin [17]. Depleting the Nox1
isoform of the catalytic subunit of NADPH oxidase using
small interfering RNA (siRNA) blocked the UVA-induced
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Figure 1: Structural differences among mammalian Nox homologues. Nox1–5 share six highly conserved transmembrane domains, while
Duox1 and Duox2 have an additional N-terminal transmembrane domain. Four conserved histidines that bind two hemes between the third
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Figure 2: Nox1 modulates intracellular signaling. Nox1 can be activated by a diverse array of stimuli, such as the binding of growth factors
to their receptor tyrosine kinases (RTK) and the stimulation by agonists such as angiotensin II. ROS produced by activated Nox1 oxidize
the cysteine residue of protein tyrosine phosphatases (PTP), inactivate these enzymes, and lead to enhanced activation of MAPK system
and PI3K. ROS may also interact with intracellular Ca2+ by enhancing the entry of Ca2+ through cell membrane. The activated intracellular
signals may further activate Nox1 or other Nox homologues, causing additional increasing of ROS. All these mechanisms may be involved in
regulating cell proliferation, differentiation, apoptosis, and migration, and angiogenesis, which are crucial components of tissue injury and
repair.
ROS increase and UVA-initiated prostaglandin E
2
(PGE
2
)
synthesis [17]. The increase in intracellular calcium was
suggested to induce the activation of Nox1 [17]. Nox1 subunit
of NADPH oxidase was also demonstrated to be of impor-
tance for UVA-induced ROS and PGE
2
production, which
might cause photosensitivity to UVA in patients with Smith-
Lemli-Opitz syndrome (SLOS) [30]. These results indicate
that UVA activates Nox1-based NADPH oxidase to produce
ROS that stimulate PGE
2
synthesis and that Nox1 may be
an appropriate target for agents designed to block UVA-
induced skin injury and tumor promotion. And another
in vitro experiment indicated that Nox1 lies downstream
of BLT2 and mediates UVB-induced ROS production and
apoptosis of HaCaT [31]. This was further testified by in vivo
BLT2-blocking and -overexpressing animal models, which
concluded that “BLT2-Nox1”-linked pathway plays a crucial
role inUVB-induced ROS generation andmediates apoptosis
in human keratinocytes [31].
4 Oxidative Medicine and Cellular Longevity
Using scratch wound motility assay, Nox1 and Nox4
isozymes of NADPH oxidase involved in enhanced ROS
production and migration of HaCaT cells with cotreatment
of hepatocyte growth factor (HGF) and transforming growth
factor-𝛽1 (TGF-𝛽1) [19]. Reepithelialization by means of
proliferation andmigration of keratinocytes from themargin
is one of the principal events in the process of wound
healing. HGF and TGF-𝛽1 as well as other various growth
factors accelerate tissue repair by enhancing proliferation
and migration of keratinocytes, fibroblasts, and endothelial
cells and promoting the formation of granulation tissue [32,
33]. Another study testified that growth factor neuregulin, a
member of the epidermal growth factor family (EGF), could
also activate ROS generation through Nox1 and Nox2 and
further increase cofilin dephosphorylation and activation in
HaCaT keratinocytes to promote cell migration [34]. Thus,
Nox1 might be beneficial in the process of tissue repair
by participating in growth factor induced enhancement of
reepithelialization. However, Nox1-generated ROS was found
to mediate EGF-induced inhibition of the Rho activity in
human colon cancer Caco2 cells that may be required for cell
migration [35].
Like growth factor, other cytokines such as inflammatory
factor signal transduction also have Nox1 and ROS involved
in epithelial cells. Nox1 is responsible for the rapid production
of ROS in response to IL-13 and Interferon-𝛾 stimulation
in human intestinal epithelial cells [36, 37]. Nox1 and ROS
respond to IL-13 treatment, regulate phosphorylation of
ERK1/2 and STAT6, and further increase the expression of
intestinal trefoil factor 3 (TFF3) and antiapoptosis factor
Bcl-xl, which contributes to the epithelial restitution and
wound healing [36]. Interestingly, Nox1 may also induce the
increased expression of the homologues Nox4 and Duox2 in
IL-13 treated intestinal epithelial cells [36].
Nox1 was demonstrated to render immortalized human
gingival mucosal keratinocytes resistant against Ca2+/serum
induced differentiation [38]. Nox1-transfected cells produced
fast dividing resistant cells and contained varying amounts of
vimentin and K8/K18, which are associated with malignant
progression in different types of human epithelial tumors
[38]. AndNox1 wasmeasured to be expressed in colon cancer
samples and cancer cell lines Caco2, HT29, and T84 and
human melanoma cell lines, which may likely be able to
facilitate cancer cell migration and invasion [29, 39, 40]. This
makes us concerned about the fact that Nox1 may be one of
the crucial signal sources triggering the formation of epithe-
lial tumor in people experiencing too much UV radiation
exposure and patients suffering chronic wounds. However,
evidence was also presented that Nox1 is not a mitogenic
oxidase and suggests that Nox1 functions as a specialized
phox-like enzyme in differentiated colon epithelium [29].
Beside intestinal epithelial cells and skin keratinocytes,
Nox1 is likely to be the key source of ROS in lung epithelial
cells after hypoxia injury and influenza virus infection [18, 41].
All of these confirm the crucial role of Nox1 in physiological
homeostasis and pathological development of epithelial tis-
sue, including defense bacterial invasion and radiation injury
of intestinal and skin epithelium, promoting cell proliferation
and migration in wound healing and tumorigenesis.
4. The Effects of Nox1 and ROS on ECM
Deposition and Fibrosis
Fibroblast and myofibroblast cells, the main sources of
extracellular matrix (ECM), especially collagen fibers, are
indispensable in wound repair. Nox1 as well as Nox4 and
Nox5 are constitutively expressed in human corneal stromal
fibroblasts in mRNA level, contributing to the main source
of superoxide [42]. The transcription of Nox1 mRNA in
mouse embryonic fibroblasts (MEFs) could be elevated by
calcium ionophore ionomycin in a dose-dependent manner
[43]. Constitutively expressed or induced expressed Nox1
in fibroblast cells and Nox1-dependent superoxide may be
potential for regulating gene expression and participating in
the processes of inflammation and wound repair, as second
signal messengers.
NIH3T3 cells overexpression of mox1 (also known as
Nox1) was shown to increase superoxide generation and cell
growth [15]. The transfected cells also had a transformed
appearance, showed anchorage-independent growth, and
produced tumors in athymic mice [15]. In another study,
Nox1-generated oxidants were shown to downregulate the
Rho activity through inactivation of the lowmolecular weight
protein-tyrosine phosphatase in K-Ras-transformed normal
rat kidney fibroblast cells, which leads to disruption of both
actin stress fibers and focal adhesions [35]. In addition,
fibroblast Nox1 was also demonstrated to form a complex
with TRADD, RIP1 and Rac1, and be responsible for TNF-
induced superoxide generation in murine fibrosarcoma L929
cells and MEF cells [44]. The large number of superoxides
caused by adding TNF to these cells induced prolonged c-
jun N-terminal kinase (JNK) activation and finally led cells
to die, while knockdown of Nox1 using siRNA inhibited cell
necrosis [44].
The fibrotic factors TGF-𝛽 and fibronectin were induced
to express muchmore in diabetes milieu through the interac-
tion of Nox1 and iNOS (inducible nitric oxide synthase) [45].
The increased expression of fibrotic factors is suggested to be
one of key mechanisms for kidney fibrogenesis of diabetes
patients. The NADPH oxidase inhibitor and antioxidant
reduced the expression of profibrotic factor TGF-𝛽 and
collagen accumulation in cultured glomerularmesangial cells
[46, 47]. And in vivo studies suggested that interventionswith
various antioxidants or NADPH oxidase inhibitor apocynin
have beneficial effects on renal fibrosis [48, 49]. However,
there is no direct or indirect evidence indicating that Nox1
rather than other Nox family members plays crucial role in
renal fibrosis.
The matricellular protein CCN1 (also known as CYR61:
cysteine-rich protein 61), which regulates diverse cellular
functions, including cell adhesion, migration, differentiation,
and survival in a cell-type and context-dependent manner, is
dynamically expressed at sites of wound repair [50]. CCN1,
highly expressed in granulation tissues during cutaneous
wound healing, drives fibroblasts into senescence and upreg-
ulates the expression of antifibrotic genes to restrict fibrosis
during tissue wound repair [51, 52]. It could induce fibroblast
senescence by binding to integrin 𝛼6𝛽1 and the heparan
sulphate proteoglycans, which further induces DNA damage
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response pathways and activates p53 and the Rac1-Nox1 com-
plex. CCN1 is unique among ECM proteins as a cell-adhesive
substrate in triggering a robust and sustained accumula-
tion of ROS necessary for senescence. The activated Nox1
results in the ROS-dependent activation of the p16INK4a/pRb
pathway, leading to senescence and concomitant expression
of antifibrotic genes [52]. Therefore, CCN1-Nox1 dependent
fibroblast senescence response in cutaneous injury functions
to curb fibrosis during wound healing.
5. Nox1 Regulates Vessel Damage and
New Vessel Formation
Endothelial cells and smooth muscle cells of vascular system
play a central role in angiogenesis and vascular remodeling
during tissue injury, and repair, including ischemic heart
disease, peripheral artery disease, acute lung injury, and
wound healing. Angiogenesis, the process of new blood
vessel growth, is dependent on cell proliferation, migration,
and capillary tube formation, which is partially regulated
by the redox system. The effects of ROS on vascular cells
are tightly regulated and dependent on the amount and
site of production as well as the intracellular balance of
prooxidant and antioxidant enzyme activity. Low levels of
ROS appear to be physiological and beneficial cellular signal
in reparative angiogenesis in response to ischemia andwound
healing [6, 53], while excess amount of ROS contributes
to endothelial cells and smooth muscle cells injury and
dysfunction [54]. In the vascular system, Nox1 mRNA has
been detected mainly in vascular smooth muscle cells but
not in adventitial cells, whereas Nox2 is localized primarily
in endothelial and adventitial cells, and Nox4 is abundantly
expressed in all of the vessel constituents [55–57]. And more
recently, all Nox isoforms (Nox1–5) were shown to exist in
human cardiovascular cells, and the whole-cell and nuclear
levels of Nox1 were reported to be similar in human vascular
endothelial cells and smoothmuscle cells [58]. Nox1 was sug-
gested to be strongly related to vascular physiopathological
changes, such as angiotensin II-induced hypertension and
aortic dissection [59, 60] and atherosclerosis development in
diabetic apolipoprotein E-deficient mice [61].
Vascular endothelial growth factor (VEGF) and its recep-
tor VEGFR play an indispensable role in angiogenesis after
tissue injury. VEGF, a potent angiogenic growth factor,
primarily through VEGFR2 (KDR/Flk1), stimulates pro-
liferation, migration, cytoskeletal reorganization, and tube
formation of endothelial cells. VEGFR is activated through
dimerization and autophosphorylation of tyrosine residues in
the cytoplasmic kinase domain [62]. The receptor activation
is followed by activation of downstream signaling pathways
such as mitogen-activated protein kinases, PI3 kinase, Src,
Akt, and eNOS, which are essential to induce endothelial cell
migration and proliferation and contribute to angiogenesis
[54, 62, 63]. NADPH oxidase is one of the major sources of
ROS in endothelial cells. VEGF can activate NADPH oxidase
and induce the production of ROS,which in turn can increase
the expression of VEGF and VEGFR and be involved in
VEGFR phosphorylation, cell proliferation, and migration
[64, 65]. The major producers of ROS in endothelial cells
have been thought to be Nox2 and Nox4, as well as xanthine
oxidase and eNOS, rather than Nox1 [66]. However, Nox1
was found to be expressed in activated sinusoidal endothelial
cells (NP31). The expression of Nox1 mRNA was increased
by approximately sixfold in NP31/kinase cells (transformed
by the introduction of a constitutively activated form of the
VEGFR1 kinase) by Northern blotting [67]. Neither Nox2
expression in NP31 cells nor induced expression of Nox2
in transformed Np31/kinase cells was detected [67]. Anti-
Nox1 siRNA treatment failed to inhibit tubulogenesis in vitro,
indicating that Nox1 together with Ras and other molecules
participated in theVEGFR1 kinase-derived tubulogenic path-
way through ROS [67].
The overexpression of Nox1 and hydrogen peroxide from
NIH 3T3 cells as well as DU-145 cells was demonstrated
to trigger the conversion of previous dormant tumors to
the angiogenic phenotype, which indicates the progress of
dormant tumors to active tumors. Nox1 led to a nearly 10-
fold increase in hydrogen peroxide levels, 4-fold induction of
VEGF mRNA in NIH 3T3 cells, and high-level expression of
VEGFR1 and VEGFR2 in the newly growing blood vessels
[65]. Zymographic analysis also showed that Nox1 expres-
sion induced increment of matrix metalloproteinase MMP-
9 bioactivity [65]. The balance of protease and antiprotease
activity in the vascular tissue is thought to play an important
role in pathogenesis of aortic dissection and aneurysm as
well as the process of angiogenesis.Matrixmetalloproteinases
are thought to favor the pathogenesis of vascular disease and
promote new blood vessels formation, whereas the specific
inhibitor tissue inhibitor of metalloproteinases (TIMPs) is
thought to be preventive. In a hypertension animal model,
angiotensin II increased TIMP-1 mRNA level in both Nox1
deficient mice and wild type mice but increased TIMP-
1 mRNA protein levels much more tremendously in Nox1
deficient mice than wild type mice [60]. This indicated that
Nox1 might be able to alter the protease and antiprotease
equilibrium, which is critical for vascular tissue injury and
wound healing.
Besides endothelial cells, vascular smooth muscle cells
participate in new vessel development through cell migra-
tion, proliferation, and extracellular matrix production after
tissue injury. Nox1 and its oxidant were shown in vitro
to contribute to vascular smooth muscle cell proliferation
and neointima formation induced by urokinase plasminogen
activator (uPA) [68]. Basic fibroblast growth factor (bFGF)
induced migration of vascular smooth muscle cells is medi-
ated by Nox1 rather than Nox4, through phosphorylation of
the adaptor protein paxillin, which is essential for migra-
tion and secretion of MMPs [16]. And an in vivo animal
study demonstrated that Nox1 and Nox2 from medial and
neointimal smooth muscle cells and adventitial fibroblasts
contributed to the increased superoxide production 3 to 15
days after balloon injury of the rat carotid artery [69]. The
activated Nox1 and oxidative stress may be critical to smooth
muscle phenotypic modulation in restenosis. Furthermore,
wire injury-induced neointima formation in the femoral
artery, along with proliferation and apoptosis, was reduced
in Nox1 knock out mice [70]. Compared to wild type
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cells, in vitro cultured Nox1 knock out smooth muscle cells
exhibited more phosphorylated cofilin (a regulator of actin
depolymerization) both basally and after PDGF stimulation,
without alteration of cofilin expression [70]. Phosphorylation
of cofilin at Ser3 inhibits its activity, which is responsible for
reduced migration of Nox1 deficient cells [70].
Nevertheless, it seems that Nox1 also can inhibit endothe-
lial cell proliferation. Chronic treatment primary human
umbilical vein endothelial cells with resveratrol (10𝜇M)
elevated ROS levels (mainly from Nox1 and Nox4) that were
linked to an accumulation of cells in S phase [71]. This
indicates that Nox1 and otherNox proteins in vascular system
have a complex regulationmechanism under different condi-
tions, which needs specific research for targeting therapy.
6. Nox1 and ROS from Other Cells Involving
Cell Damage and Dysfunction
As mentioned above Nox1 is broadly expressed in various
cell types besides epithelial cell, endothelial cell, and vascular
smooth muscle cell. Nox1 is expressed in BeWo choriocarci-
noma cells, which can be activated byEGF [72].This is further
confirmed by the evidence that in placental tissues Nox1
was localized in syncytiotrophoblasts, in villous vascular
endothelium, and in some stromal cells, which is increased
in patients with preeclampsia [72]. Additionally, expression
of Nox1 protein and ROS is increased in pancreatic beta cells
in response to proinflammatory cytokines stimulation, which
might lead to cell dysfunction and death [73].Moreover, Nox1
is suggested to play critical roles in spermatogonial stem cells
self-renewal via the activation of the p38 MAPK and JNK
[74].
7. Nox1 and Inflammation
Inflammation following injury is the essential process for
tissue repair. Inflammatory cells such as neutrophils and
macrophages are major source of ROS, which are needed for
scavenging bacteria and necrotic tissue. As mentioned above,
the activation of Nox1 and rapid production of ROS could be
induced by inflammatory cytokines like IL-13 and interferon-
𝛾 [36, 37]. Nox1 and its derived ROS further participate in
intracellular signaling processes regulating gene expression,
which contributes to cell proliferation, differentiation, and
tissue repair.
ROS may serve as the primary signal inducing the
migration of inflammatory cells directly after tissue injury. In
a study performed on zebrafish larvae, a rapid and sustained
increase of hydrogen peroxide at the wound margin was
detected upon local injury of the tail fin, which occurred
before the recruitment of leukocytes, suggesting that the
source of hydrogen peroxide was the tail fin epithelium, not
leukocytes [13]. This finding contrasts with the prevailing
view that the ROS molecules found at the wound site
are mainly produced by oxidative bursts of inflammatory
cells. Furthermore, Duox1 in epithelium was shown to be
the Nox isoform responsible for the early ROS production
after epithelial injury [13]. As of now, there is no evidence
indicating that local Nox1 can be activated upon tissue
injury and form a ROS gradient activating migration of
inflammatory cells, as its homologue Duox1 did in zebrafish.
However, Nox1 and its derived ROS can indirectly affect
inflammation by regulating inflammatory cytokines such as
PGE
2
, CCL2, CCL3, CXCL2, IL-1𝛽, GM-CSF, and TNF-𝛼
[17, 30, 41].
8. Conclusion and Future Perspectives
NADPH oxidase, whose only function is ROS production,
has been extensively investigated in many cell types of both
mammalian and plant. Nox1, one member of the NADPH
oxidase family, is not only constitutively expressed in a variety
of tissues, but also induced to increase expression in both
mRNA and protein levels under many circumstances. Nox1
is most expressed by intestinal epithelium and participates in
the maintenance of epithelial barrier andmucosal homeosta-
sis, including promoting intestinal mucosa wound healing
by activation of focal cell matrix adhesion proteins and cell
motility. It could also be induced and activated by growth
factors, inflammatory cytokines, and UV injury in skin and
mucosal keratinocytes in vitro, regulating cell proliferation,
differentiation, and migration. In addition, Nox1 and ROS
have been suggested to regulate cellular differentiation, ECM
deposition, and fibrosis formation both in vitro and in
vivo. As for in the processes of blood vessel damage and
regeneration, Nox1 from smooth muscle cell and endothelial
cell, together with some of its homologues (Nox2 and Nox4),
is critical for vascular injury response and pathology. Nox1
and its derived ROS are also involved in inflammatory
response caused by injury or infection through interaction
with inflammatory cells. In short, Nox1 and its derived
reactive oxygen species are crucial intracellular signaling
regulators involving cell proliferation, differentiation, migra-
tion, extracellular matrix production and deposition, and
inflammatory process after tissue injury, which contribute to
the processes of tissue repair (Table 1).
Although a large number of evidence indicates that Nox1
has critical effect upon the process of tissue repair, there are
many open questions regarding the complex mechanisms of
Nox1. Nox1, as well as some of its homologues, has broad
tissue and cellular distribution and is either constitutively
expressed or stimulatively upregulated. One tissue or cell may
express various NADPH oxidase molecules, and the same
cell type in different tissues may have different dominant
Nox isoforms at mRNA and protein levels [7, 15, 55–57].
Nox molecules are activated by different stimuli and present
the function of proinjuring or protection [41, 75]. Cross talk
exists between Nox homologues so that the activation of
one Nox might further activate other Nox molecules in the
same cell through the production and regulation of ROS [36,
76]. Additionally, Nox1 accomplishes its functions through
complicated and unique intracellular signaling pathways
upon disparate stimuli. Therefore, in order to get improved
understanding of the roles of Nox1 in the process of tissue
repair, the specificity of cell and tissue, the type of injury and
severity of injury, the specific intracellular signaling, and the
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Table 1: Nox1 expression, intracellular signaling, and function.
Cells involved Intracellular signaling Function References
Intestinal epithelial cell; colon
carcinoma cells (Caco2 and HT29)
IL13-Nox1-ERK/STAT6-TFF3/Bcl-xl;
Nox1-RhoA-alpha3 integrin
Proliferation and
differentiation; migration [29, 36, 37, 40]
HaCaT; GM16 Ca
2+-Nox1-PGE2;
Ca2+/serum-Nox1-vimentin/K8/K18
Proliferation and host defense;
skin injury; apoptosis;
migration
[17, 19, 22, 30, 31, 34, 38]
Lung epithelial cell Nox1-JNK/ERK/Caspase-3 Cell death and protection [18, 41]
Corneal stromal fibroblast
May participate in
inflammation [42]
Mouse embryonic fibroblast Ischemia-reperfusion injury [43]
NIH 3T3 fibroblast; rat kidney
fibroblast
Ras-Nox1-Rho-actin stress fibers and
focal adhesions
Tumorigenic conversion [15, 35]
Fibrosarcoma L929 cells TNF-TRADD/RIP1/Rac1/Nox1 Necrosis [44]
Human BJ foreskin fibroblast and
IMR-90 lung fibroblast
CCN1-Nox1/Rac-ERK/p38
MAPK-p16INK4a /pRb
Senescence and expression of
antifibrotic genes [52]
Mouse vessel Angiotensin II-Nox1-nitric oxide Hypertension [59]
Mouse aorta Angiotensin II-Nox1-tissue inhibitor ofmetalloproteinase 1
Aortic dissection [60]
Human aortic endothelial cell Hyperglycemia-Nox1-proinflammatoryand profibrotic markers
Atherosclerosis [61]
Rat kidney cell; tumor cells and vessel;
sinusoidal endothelial cell
K-Ras-Nox1-ERK-sp1-VEGF;
Nox1-VEGF/VEGFR/MMP
Upregulate VEFG expression;
increase tumorigenicity and
upregulate VEGF/VEGFR and
MMP; tubulogenic
[64, 65, 67]
Vascular smooth muscle cell uPA-Nox1/Nox4; PDGF-Nox1-cofilin Migration; proliferation andnecrosis [68–70]
potential cross talk between various Nox homologues remain
to be elucidated.
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